BioLargo, Inc.
BLGO
$0.219
-$0.0027-1.22%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.20% | -13.91% | -88.83% | -21.77% | -7.56% |
| Total Depreciation and Amortization | -4.71% | 26.87% | -1.47% | -13.92% | 92.68% |
| Total Amortization of Deferred Charges | 39.29% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.38% | -129.95% | 208.50% | -198.52% | -21.62% |
| Change in Net Operating Assets | -42.46% | 39.04% | -24.71% | -11,987.50% | -98.65% |
| Cash from Operations | -15.74% | 4.49% | -18.27% | -972.85% | -131.39% |
| Capital Expenditure | -- | -- | 164.10% | 89.11% | 58.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -46.15% | 89.11% | 58.52% |
| Total Debt Issued | 22.20% | -31.71% | -- | -- | -- |
| Total Debt Repaid | -25.00% | -100.00% | 50.00% | -33.33% | 40.00% |
| Issuance of Common Stock | 612.54% | -- | -- | -23.35% | -7.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -100.75% | -- | -- | -- |
| Cash from Financing | 227.14% | -45.60% | 108.38% | -23.52% | -7.76% |
| Foreign Exchange rate Adjustments | 100.00% | -142.55% | 291.67% | 119.67% | -163.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.17% | -194.61% | 62.17% | -305.83% | -46.17% |